ABOS
Price
$1.35
Change
-$0.05 (-3.57%)
Updated
Aug 1 closing price
Capitalization
81.77M
16 days until earnings call
CLYM
Price
$1.45
Change
+$0.05 (+3.57%)
Updated
Aug 1 closing price
Capitalization
97.98M
17 days until earnings call
Interact to see
Advertisement

ABOS vs CLYM

Header iconABOS vs CLYM Comparison
Open Charts ABOS vs CLYMBanner chart's image
Acumen Pharmaceuticals
Price$1.35
Change-$0.05 (-3.57%)
Volume$89.04K
Capitalization81.77M
Climb Bio
Price$1.45
Change+$0.05 (+3.57%)
Volume$145.78K
Capitalization97.98M
ABOS vs CLYM Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CLYM commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and CLYM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (ABOS: $1.39 vs. CLYM: $1.45)
Brand notoriety: ABOS and CLYM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 29% vs. CLYM: 51%
Market capitalization -- ABOS: $81.77M vs. CLYM: $97.98M
ABOS [@Biotechnology] is valued at $81.77M. CLYM’s [@Biotechnology] market capitalization is $97.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCLYM’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CLYM’s FA Score: 1 green, 4 red.
According to our system of comparison, CLYM is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 3 TA indicator(s) are bullish while CLYM’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 3 bullish, 5 bearish.
  • CLYM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CLYM is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -13.35% price change this week, while CLYM (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

CLYM is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($98M) has a higher market cap than ABOS($81.8M). CLYM YTD gains are higher at: -19.444 vs. ABOS (-21.512). CLYM has higher annual earnings (EBITDA): -50.37M vs. ABOS (-111.98M). ABOS has more cash in the bank: 149M vs. CLYM (98.1M). CLYM has less debt than ABOS: CLYM (474K) vs ABOS (29M). ABOS (0) and CLYM (0) have equivalent revenues.
ABOSCLYMABOS / CLYM
Capitalization81.8M98M83%
EBITDA-111.98M-50.37M222%
Gain YTD-21.512-19.444111%
P/E RatioN/AN/A-
Revenue00-
Total Cash149M98.1M152%
Total Debt29M474K6,118%
TECHNICAL ANALYSIS
Technical Analysis
ABOSCLYM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 16 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCCPY6.540.23
+3.65%
Technopro Holdings Inc.
NOPMF11.430.27
+2.39%
Neo Performance Materials Inc.
BZLFY15.030.06
+0.39%
Bunzl plc
SABOF0.39N/A
N/A
Sabio Holdings Inc.
GOGY0.02N/A
-2.29%
Golden Grail Technology Corp

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-3.57%
CRBU - ABOS
52%
Loosely correlated
-3.94%
BEAM - ABOS
49%
Loosely correlated
-4.46%
GLSI - ABOS
49%
Loosely correlated
+1.37%
FHTX - ABOS
48%
Loosely correlated
-4.95%
SYRE - ABOS
47%
Loosely correlated
-4.18%
More